Jackson NA - Search Results

1

Fast-Track Zika Vaccine Development - Is It Possible?

Thomas SJ, L'Azou M, Barrett AD, Jackson NA. Thomas SJ, et al. Among authors: jackson na. N Engl J Med. 2016 Sep 29;375(13):1212-6. doi: 10.1056/NEJMp1609300. N Engl J Med. 2016. PMID: 27682032 Free article. No abstract available.

2

A recombinant live attenuated tetravalent vaccine for the prevention of dengue.

Guy B, Noriega F, Ochiai RL, L'azou M, Delore V, Skipetrova A, Verdier F, Coudeville L, Savarino S, Jackson N. Guy B, et al. Expert Rev Vaccines. 2017 Jul;16(7):1-13. doi: 10.1080/14760584.2017.1335201. Epub 2017 Jun 7. Expert Rev Vaccines. 2017. PMID: 28590795 Review.

3

Immune correlates of protection for dengue: State of the art and research agenda.

Katzelnick LC, Harris E; Participants in the Summit on Dengue Immune Correlates of Protection. Katzelnick LC, et al. Vaccine. 2017 Aug 24;35(36):4659-4669. doi: 10.1016/j.vaccine.2017.07.045. Epub 2017 Jul 28. Vaccine. 2017. PMID: 28757058 Free PMC article.

4

Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005-2014).

L'Azou M, Assoukpa J, Fanouillere K, Plennevaux E, Bonaparte M, Bouckenooghe A, Frago C, Noriega F, Zambrano B, Ochiai RL, Guy B, Jackson N. L'Azou M, et al. Trans R Soc Trop Med Hyg. 2018 Apr 1;112(4):158-168. doi: 10.1093/trstmh/try037. Trans R Soc Trop Med Hyg. 2018. PMID: 29800279 Free PMC article. Review.

5

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease.

Hadinegoro SR, Arredondo-García JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, Muhammad Ismail HI, Reynales H, Limkittikul K, Rivera-Medina DM, Tran HN, Bouckenooghe A, Chansinghakul D, Cortés M, Fanouillere K, Forrat R, Frago C, Gailhardou S, Jackson N, Noriega F, Plennevaux E, Wartel TA, Zambrano B, Saville M; CYD-TDV Dengue Vaccine Working Group. Hadinegoro SR, et al. N Engl J Med. 2015 Sep 24;373(13):1195-206. doi: 10.1056/NEJMoa1506223. Epub 2015 Jul 27. N Engl J Med. 2015. PMID: 26214039 Free article. Clinical Trial.

6

Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward.

Guy B, Briand O, Lang J, Saville M, Jackson N. Guy B, et al. Vaccine. 2015 Dec 10;33(50):7100-11. doi: 10.1016/j.vaccine.2015.09.108. Epub 2015 Oct 20. Vaccine. 2015. PMID: 26475445 Free article. Review.

7

Dengue vaccine: hypotheses to understand CYD-TDV-induced protection.

Guy B, Jackson N. Guy B, et al. Nat Rev Microbiol. 2016 Jan;14(1):45-54. doi: 10.1038/nrmicro.2015.2. Epub 2015 Dec 7. Nat Rev Microbiol. 2016. PMID: 26639777 Review.

8

Vaccination Against Dengue: Challenges and Current Developments.

Guy B, Lang J, Saville M, Jackson N. Guy B, et al. Annu Rev Med. 2016;67:387-404. doi: 10.1146/annurev-med-091014-090848. Epub 2015 Oct 23. Annu Rev Med. 2016. PMID: 26515983 Review.

9

Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2-16 Years in Asia and Latin America.

Olivera-Botello G, Coudeville L, Fanouillere K, Guy B, Chambonneau L, Noriega F, Jackson N; CYD-TDV Vaccine Trial Group. Olivera-Botello G, et al. J Infect Dis. 2016 Oct 1;214(7):994-1000. doi: 10.1093/infdis/jiw297. Epub 2016 Jul 14. J Infect Dis. 2016. PMID: 27418050 Free PMC article.

10

Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination.

Vigne C, Dupuy M, Richetin A, Guy B, Jackson N, Bonaparte M, Hu B, Saville M, Chansinghakul D, Noriega F, Plennevaux E. Vigne C, et al. Hum Vaccin Immunother. 2017 Sep 2;13(9):2004-2016. doi: 10.1080/21645515.2017.1333211. Epub 2017 Jun 9. Hum Vaccin Immunother. 2017. PMID: 28598256 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page